PMID- 35222713 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220301 IS - 1792-1015 (Electronic) IS - 1792-0981 (Print) IS - 1792-0981 (Linking) VI - 23 IP - 3 DP - 2022 Mar TI - Long non-coding RNA TUG1 sponges microRNA-9 to protect podocytes from high glucose-induced apoptosis and mitochondrial dysfunction via SIRT1 upregulation. PG - 236 LID - 10.3892/etm.2022.11161 [doi] LID - 236 AB - Podocyte apoptosis and mitochondrial dysfunction serve a major role in diabetic nephropathy progression. The present study revealed a molecular mechanism regulating podocyte apoptosis and mitochondrial dysfunction. In vitro models were established using conditionally immortalized mouse podocyte clonal cells treated with high glucose (HG). Reverse quantitative-transcription PCR were used to detect gene expression, western blotting and immunofluorescence were used to detect protein expression, Cell Counting Kit-8 was used to detect cell viability and flow cytometry was used to detect cell apoptosis. HG treatment in the mouse podocyte clonal cells downregulated taurine-upregulated gene 1 (TUG1) expression and decreased viability in a dose-dependent manner. In addition, TUG1 knockdown (KD) increased HG-induced apoptosis, while TUG1 overexpression (OE) reduced HG-induced apoptosis in podocytes. HG-induced mitochondrial dysfunction was identified in podocytes, with increased reactive oxygen species levels, decreased complex I/III activity and decreased basal/maximal oxygen consumption rate. TUG1 KD worsened HG-induced mitochondrial dysfunction, and TUG1 OE reversed these effects. At the molecular level, TUG1 was revealed to promote sirtuin 1 (SIRT1) expression by sponging microRNA (miR)-9, and SIRT1 OE reversed the HG-induced apoptosis and mitochondrial dysfunction increased by TUG1 KD. The present data indicated that downregulation of TUG1 induced by HG was associated with HG-induced apoptosis and mitochondrial dysfunction in podocytes, and that TUG1 protected HG-induced podocytes by promoting SIRT1 expression via miR-9 inhibition. CI - Copyright: (c) Lei et al. FAU - Lei, Min AU - Lei M AD - Department of Nephrology, Affiliated Hospital and Clinical Medical College of Chengdu University, Jinniu, Chengdu, Sichuan 610081, P.R. China. FAU - Ke, Guibao AU - Ke G AD - Department of Nephrology, Affiliated Hospital and Clinical Medical College of Chengdu University, Jinniu, Chengdu, Sichuan 610081, P.R. China. FAU - Wang, Yan AU - Wang Y AD - Department of Nephrology, Affiliated Hospital and Clinical Medical College of Chengdu University, Jinniu, Chengdu, Sichuan 610081, P.R. China. FAU - Luo, Dan AU - Luo D AD - Department of Nephrology, Affiliated Hospital and Clinical Medical College of Chengdu University, Jinniu, Chengdu, Sichuan 610081, P.R. China. FAU - Hu, Yao AU - Hu Y AD - Department of Nephrology, Affiliated Hospital and Clinical Medical College of Chengdu University, Jinniu, Chengdu, Sichuan 610081, P.R. China. LA - eng PT - Journal Article DEP - 20220124 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC8815052 OTO - NOTNLM OT - apoptosis OT - high glucose OT - mitochondrial dysfunction OT - podocytes COIS- The authors declare that they have no competing interests. EDAT- 2022/03/01 06:00 MHDA- 2022/03/01 06:01 PMCR- 2022/01/24 CRDT- 2022/02/28 05:35 PHST- 2021/04/01 00:00 [received] PHST- 2021/09/16 00:00 [accepted] PHST- 2022/02/28 05:35 [entrez] PHST- 2022/03/01 06:00 [pubmed] PHST- 2022/03/01 06:01 [medline] PHST- 2022/01/24 00:00 [pmc-release] AID - ETM-23-3-11161 [pii] AID - 10.3892/etm.2022.11161 [doi] PST - ppublish SO - Exp Ther Med. 2022 Mar;23(3):236. doi: 10.3892/etm.2022.11161. Epub 2022 Jan 24.